Allen (Chunlong) Guo

Allen (Chunlong) Guo is the Co-Founder and CEO of Shuimu BioSciences, a biotech startup that leverages cryo-EM (cryogenic electron microscopy) and AI technologies for drug discovery.1

Background and Expertise

Allen Guo has a diverse background that spans several fields:

• Drug Discovery: He leads Shuimu BioSciences, which focuses on accelerating drug development using cutting-edge technologies.1
• Artificial Intelligence: The company he co-founded integrates AI with cryo-EM to revolutionize the drug discovery process.1
• Cryo-EM Technology: Shuimu BioSciences operates one of the largest commercial cryo-EM facilities in the world.1

Company Leadership

Under Allen Guo's leadership, Shuimu BioSciences has:

• Partnered with Thermo Fisher to build a state-of-the-art cryo-EM facility.1
• Expanded its capacity to eight 300kV cryo-EMs, making it the largest such facility globally.1
• Developed a novel drug discovery platform that combines high-throughput cryo-EM with AI algorithms.1

Vision and Perspective

Allen Guo has expressed a forward-thinking vision for the pharmaceutical industry, stating, "In the future, all drug development will take advantage of cryo-EM and AI".1 This perspective aligns with the growing trend of tech giants investing in life sciences and the increasing importance of AI in biotechnology.

Professional Network

Allen Guo's LinkedIn profile can be found under the username "along".2 He is based in Cambridge, Massachusetts, and has a significant following on the platform with over 11,000 followers.2